FDA approves first monoclonal antibody injection for atopic dermatitis

The US Food and Drug Administration (FDA), which is responsible for evaluating the safety and efficacy of medicines in the United States, has approved the use of dupilumab (Dupixent; Regeneron Pharmaceuticals) to treat adults with atopic dermatitis.
Dupilumab is the first monoclonal antibody t…